ECCO Cardiovascular Disorders Practice Test

In the context of right ventricular myocardial infarction (RVMI), vasodilators are often used cautiously because they can exacerbate hypotension, which is a significant concern in this condition. RVMI can lead to inadequate preload due to the compromised function of the right ventricle. Administering vasodilators can further reduce venous return, worsening the cardiac output and potentially leading to cardiovascular collapse. Therefore, while vasodilators may be helpful in other scenarios to manage blood pressure or reduce myocardial oxygen demand, in patients with RVMI, the risk of hypotensive episodes makes their use problematic.

Other options, such as anticoagulants, statins, and proton pump inhibitors, do not carry the same degree of risk relative to hypotension and are generally not as critically impactful in the context of RVMI. Anticoagulants are important for preventing thromboembolic events, statins are often used for their long-term cardiovascular benefit, and proton pump inhibitors are typically utilized for managing gastric acid, showing that while they may have roles in cardiovascular care, they do not have the same immediate implications on hemodynamics as vasodilators do in RVMI.